Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970

International Journal of Cancer

Volumn 122, Issue 3, 2008, Pages 639-642

  Verhoeven, Rob ^a,b   Houterman, Saskia ^a,c   Kiemeney, Bart ^b   Koldewijn, Evert ^c,d   Coebergh, Jan Willem ^a,e  

^a Eindhoven Cancer Registry   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c IKZ   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Birth cohort; Incidence; Mortality; Testicular cancer

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; COHORT ANALYSIS; HUMAN; LYMPH NODE METASTASIS; MALE; NETHERLANDS; POISSON DISTRIBUTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SEMINOMA; TESTIS CANCER; TUMOR LOCALIZATION;

ADULT; AGE DISTRIBUTION; COHORT STUDIES; HUMANS; INCIDENCE; MALE; MORTALITY; NETHERLANDS; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 37349071796     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23061     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003;170:5-11.
3. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer 2005;115:822-7.
4. Post PN, Casparie MK, ten Kate FJ, Oosterhuis JW. [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)]. Ned Tijdschr Geneeskd 2004;148:1150-4.
5. Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E. Western and eastern European trends in testicular cancer mortality. Lancet 2001;357:1853-4.
6. Einhorn LH. Curing metastatic testicular cancer. Proc Natl Acad Sci USA 2002;99:4592-5.
7. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 2006;118:3099-111.
8. Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, Rahu M, Stengrevics A, Storm H, Tretli S, Kurtinaitis J, Tyczynski JE, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004;13:2157-66.
9. Jacobsen R, Moller H, Thoresen SO, Pukkala E, Kjaer SK, Johansen C. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl 2006;29:199-204.
10. Moller H. Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 2001;16:1007-11.
11. Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Akre O, Hakulinen T. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996;88:727-33.
12. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63-70.
13. Wanderas EH, Tretli S, Fossa SD. Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer 1995;31A:2044-8.
14. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer 2005;116:331-9.
15. Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ, Voogd AO. Cancer incidence, care and survival in the South of the Netherlands, 1955-1999: a report of the Eindhoven Cancer Registry with cross border implications, 1st edn. Eindhoven: Comprehensive Cancer Centre South (IKZ), 2001.
16. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International classification of Diseases for Oncology, 3 ed. Geneva: World Health Organization, 2000.
17. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 1987;6:449-67.
18. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 1987;6:469-81.
19. SignaleringscommissieKanker. Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. Amsterdam: KWF Kankerbestrijding, 2004.
20. Spermon JR, Hoffmann AL, Horenblas S, Verbeek AL, Witjes JA, Kiemeney LA. The efficacy of different follow-up strategies in clinical stage. I. Non-seminomatous Germ Cell Cancer: a Markov simulation study. Eur Urol 2005;48:258-67; discussion 67-8.
21. Spermon JR, Witjes JA, Kiemeney LA. Efficacy of routine follow-up after first-line treatment for testicular cancer. World J Urol 2004;22:235-43.
22. Bay K, Asklund C, Skakkebaek NE, Andersson AM. Testicular dysgenesis syndrome: possible role of endocrine disrupters. Best Pract Res 2006;20:77-90.
23. Richiardi L, Akre O, Lambe M, Granath F, Montgomery SM, Ekboin A. Birth order, sibship size, and risk for germ-cell testicular cancer. Epidemiology 2004;15:323-9.
24. Hatton MQ, Paul J, Harding M, MacFarlane G, Robertson AG, Kaye SB. Changes in the incidence and mortality of testicular cancer in Scotland with particular reference to the outcome of older patients treated for non-seminomatous germ cell tumours. Eur J Cancer 1995;31A:1487-91.
25. Power DA, Brown RS, Brock CS, Payne HA, Majeed A, Babb P. Trends in testicular carcinoma in England and Wales, 1971-99. BJU Int 2001;87:361-5.
26. Levi F, Lucchini F, Boyle P, Negri E, La Vecchia C. Testicular cancer mortality in Eastern Europe. Int J Cancer 2003;105:574.
27. Verhoeven RHA, Coebergh JWW, Kiemeney LALM, Koldewijn EL, Houterman S. Testicular cancer: trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970. Eur J Cancer. In press 2007.